Medicaid coverage of semaglutide varies significantly by state, and most state programs do not cover it for weight loss

Medicaid will cover semaglutide (sold as Ozempic, Wegovy, or Rybelsus) only in specific circumstances, and those circumstances differ from state to state. The drug is approved by the FDA for type 2 diabetes and for chronic weight management, but Medicaid programs treat these two uses very differently. Most states cover semaglutide when prescribed for diabetes. Very few cover it for weight loss alone, and those that do usually require documentation that you have tried and failed other treatments first.

Whether your state Medicaid program will cover semaglutide depends on three things: what you are taking it for, what your state's formulary (the list of covered drugs) includes, and whether your doctor's prescription meets the program's prior authorization requirements. You will need to contact your state Medicaid office or your managed care plan directly to find out what applies to you, because the answer cannot be determined from federal policy alone.

Key Takeaways

  • Most state Medicaid programs cover semaglutide for type 2 diabetes but not for weight loss without diabetes.
  • A small number of states have added semaglutide to their weight-loss coverage, usually only after other treatments have failed and with documented prior attempts.
  • Your state Medicaid program or your managed care plan makes the coverage decision, not Medicare or the federal government.
  • Your doctor will need to submit a prior authorization request showing medical necessity before the prescription is filled, even in states that do cover the drug.
  • If your state does not cover semaglutide, you may be able to purchase it through a discount program or pharmaceutical assistance program run by the manufacturer.

Semaglutide for diabetes versus weight loss: why coverage differs

Semaglutide is a GLP-1 receptor agonist, a class of drug originally developed to treat type 2 diabetes. The FDA approved it for diabetes under the brand name Ozempic in 2017. In 2021, the FDA approved a higher-dose version under the brand name Wegovy specifically for chronic weight management in people without diabetes. This distinction matters because Medicaid programs treat FDA-approved diabetes medications differently from weight-loss drugs.

For diabetes, most state Medicaid programs include semaglutide on their formulary because it is an established treatment for a chronic disease that Medicaid is required to cover. For weight loss, the situation is reversed: most states do not cover it, viewing it as a lifestyle or cosmetic treatment rather than a medical necessity. A handful of states—including California, New York, and Vermont—have begun covering semaglutide for weight management, but they typically require that you have a BMI above a certain threshold (often 30 or higher) and that you have documented attempts at weight loss through diet, exercise, or other medications.

How to find out what your state Medicaid program covers

Contact your state Medicaid agency directly. You can find the phone number and website for your state's program through the Centers for Medicare & Medicaid Services (CMS) website at medicaid.gov. When you call, have your Medicaid member ID ready and ask specifically whether semaglutide is covered for your condition—be clear about whether you are asking about diabetes or weight loss.

If you are enrolled in a Medicaid managed care plan (a private insurance company contracted by your state to deliver Medicaid benefits), call the plan's member services number on your insurance card instead. The plan, not the state, makes coverage decisions for most services. Ask whether semaglutide is on the plan's formulary and whether your doctor will need to request prior authorization. If it is not covered, ask whether there is an appeal process or whether the plan covers similar drugs like tirzepatide (Mounjaro or Zepbound).

Prior authorization and what your doctor needs to submit

Even in states where semaglutide is covered, your doctor will almost always need to submit a prior authorization request before the prescription can be filled. Prior authorization is a process where your doctor provides medical documentation to the Medicaid program or plan, explaining why the drug is medically necessary for you specifically. The program then approves or denies the request.

For diabetes, prior authorization typically requires documentation that you have type 2 diabetes, your current blood sugar levels or A1C test results, and sometimes evidence that you have tried other diabetes medications first. For weight loss, the bar is higher: your doctor will need to document your BMI, your weight-loss history, any previous treatments you have tried, and any weight-related health conditions you have (such as high blood pressure or sleep apnea). Prior authorization can take anywhere from a few days to several weeks, so ask your doctor to submit the request as soon as possible.

States that cover semaglutide for weight loss

As of 2024, a small but growing number of states have added semaglutide or other GLP-1 drugs to their Medicaid coverage for weight management. California, New York, and Vermont have explicitly covered it. Other states may cover it on a case-by-case basis through their prior authorization process, even if it is not formally listed on the state formulary. Some states cover tirzepatide (Mounjaro or Zepbound) for weight loss but not semaglutide, or vice versa.

Coverage rules in these states typically require a BMI of 30 or higher (or 27 or higher if you have weight-related health conditions), documented attempts at weight loss through other methods, and a prescription from your doctor. Some states also require that you have tried and failed at least one other weight-loss medication. Because these policies change and vary by managed care plan within each state, you must contact your specific plan to confirm what is covered for you.

What to do if your state does not cover semaglutide

If your state Medicaid program does not cover semaglutide, you have several options. First, ask your doctor whether a different medication on your plan's formulary might work for your condition—this could be another GLP-1 drug, a different class of diabetes or weight-loss medication, or an older drug that is less expensive. Your doctor can also request a formulary exception, asking the plan to cover semaglutide even though it is not on the standard list, though this is rarely approved unless there is documented medical reason you cannot take the alternatives.

Second, contact the manufacturer (Novo Nordisk for Ozempic and Wegovy, or Eli Lilly for Mounjaro and Zepbound). Both companies run patient assistance programs that provide the drug free or at reduced cost to people who meet income requirements and do not have insurance coverage. You can also look into discount programs like GoodRx, which negotiate prices with pharmacies and may offer semaglutide at a lower out-of-pocket cost than the full retail price.

Appeals and what to do if coverage is denied

If your doctor requests prior authorization and the Medicaid program or plan denies it, you have the right to appeal. Your plan is required to send you a written notice explaining why the request was denied and how to file an appeal. You typically have 60 days from the date of the denial to submit an appeal, and your doctor can submit additional medical information supporting the need for the drug.

An appeal goes to a different reviewer within the plan or state program, and you can also request an expedited appeal if you believe the delay in treatment poses a serious risk to your health. If the appeal is denied again, you may be able to request an independent external review, where someone outside the plan reviews the decision. Ask your plan's member services for the specific appeal process and deadlines that apply to your situation.

Frequently Asked Questions

Will Medicaid cover semaglutide if I have type 2 diabetes?

Most state Medicaid programs cover semaglutide for type 2 diabetes because it is an FDA-approved diabetes medication. Your doctor will need to submit a prior authorization request with documentation of your diabetes diagnosis and current blood sugar levels. Contact your state Medicaid program or managed care plan to confirm coverage in your state.

What is the difference between Ozempic, Wegovy, and Rybelsus?

All three are semaglutide, but they are different formulations and doses. Ozempic is for diabetes, Wegovy is for weight loss, and Rybelsus is an oral tablet for diabetes. Medicaid coverage depends on which formulation your doctor prescribes and what your state covers. Your doctor will choose based on your condition and your plan's formulary.

Can I appeal if my state Medicaid program denies coverage?

Yes. You have the right to appeal any coverage denial. Your plan must send you a written notice explaining the denial and the appeal process. Your doctor can submit additional medical information with your appeal. You typically have 60 days to file, and you can request an expedited appeal if the delay poses a serious health risk.

What if I cannot afford semaglutide even with Medicaid?

Contact the drug manufacturer's patient assistance program—Novo Nordisk and Eli Lilly both offer free or reduced-cost medication to people who meet income requirements. You can also ask your doctor about other weight-loss or diabetes medications that your plan does cover, or explore discount pharmacy programs like GoodRx.

Does Medicare cover semaglutide differently than Medicaid?

Yes. Medicare Part D (prescription drug coverage) has its own formulary and coverage rules that differ from Medicaid. Medicare generally does not cover semaglutide for weight loss, but coverage for diabetes varies by plan. If you have both Medicare and Medicaid (dual may be able to access), your Medicaid program is usually the primary payer for prescriptions.